WCM
IBB icon

Weatherstone Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Weatherstone Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-13,461
Closed -$946K – 78
2013
Q3 		$946K Buy
+13,461
New +$882K 0.25% 34

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Weatherstone Capital Management's IBB Position: Q4 2013 in Review

Weatherstone Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2013, closing a stake of 13,461 shares — an estimated $946K sold.

Weatherstone Capital Management first reported a position in IBB in Q3 2013 and held it in 1 quarter. The position peaked at $946K in Q3 2013. 278 funds tracked by Wall St. Rank hold IBB as of Q4 2013.

  • Weatherstone Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2013 after selling out during the quarter.
  • Weatherstone Capital Management sold 13,461 iShares Biotechnology ETF shares in Q4 2013, an estimated $946K.
  • Weatherstone Capital Management first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 1 quarter.
  • Weatherstone Capital Management's iShares Biotechnology ETF position peaked at $946K in Q3 2013.
  • 278 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2013.

Based on Weatherstone Capital Management's 13F filing for Q4 2013, filed 18 Feb 2014.